Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Moeendarbari, Sina ^a   Tekade, Rakesh ^b   Mulgaonkar, Aditi ^b   Christensen, Preston ^b   Ramezani, Saleh ^b   Hassan, Gedaa ^b   Jiang, Ruiqian ^a   Öz, Orhan K ^b   Hao, Yaowu ^a   Sun, Xiankai ^a,b,c  

^a University of Texas at Arlington   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD; METAL NANOPARTICLE; NANOMATERIAL; PALLADIUM; RADIOISOTOPE;

ANIMAL; BRACHYTHERAPY; CHEMISTRY; DIAGNOSTIC IMAGING; HUMAN; MALE; MOUSE; PARTICLE SIZE; POSITRON EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; SCID MOUSE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; THERANOSTIC NANOMEDICINE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BRACHYTHERAPY; CELL LINE, TUMOR; GOLD; HUMANS; MALE; METAL NANOPARTICLES; MICE; MICE, SCID; NANOSTRUCTURES; PALLADIUM; PARTICLE SIZE; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOISOTOPES; THERANOSTIC NANOMEDICINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, HETEROLOGOUS;

EID: 84957584263     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20614     Document Type: Article

References (43)

1. Patel, R. R., Arthur, D. W. The emergence of advanced brachytherapy techniques for common malignancies. Hematology-Oncology Clinics of North America 20, 97-118 (2006).
2. Yoshioka, Y. Current status and perspectives of brachytherapy for prostate cancer. International Journal of Clinical Oncology 14, 31-36 (2009).
3. Bensaleh, S., Bezak, E., Borg, M. Review of MammoSite brachytherapy: Advantages, disadvantages and clinical outcomes. Acta Oncologica 48, 487-494 (2009).
4. Cosset, J. M. et al. Brachytherapy for prostate cancer: old concept, new techniques. Bulletin Du Cancer 93, 761-766 (2006).
5. Semenova, E., Finger, P. T. Palladium-103 Radiation Therapy for Small Choroidal Melanoma. Ophthalmology 120, 2353-2357 (2013).
6. Wilt, T. J., Thompson, I. M. Clinically localised prostate cancer. British Medical Journal 333, 1102-1106 (2006).
7. Kanikowski, M., Skowronek, J., Kubaszewska, M., Chiche?, A., Milecki, P. Permanent implants in treatment of prostate cancer. Reports of Practical Oncology & Radiotherapy 13, 150-167 (2008).
8. Merrick, G. S., Wallner, K. E., Butler, W. M. Permanent Interstitial Brachytherapy for the Management of Carcinoma of the Prostate Gland. The Journal of Urology 169, 1643-1652 (2003).
9. Peschel, R. E., Colberg, J. W., Chen, Z., Nath, R., Wilson, L. D. Iodine 125 versus palladium 103 implants for prostate cancer: Clinical outcomes and complications. Cancer J. 10, 170-174 (2004).
10. Shukla, R. et al. Laminin receptor specific therapeutic gold nanoparticles ((AuNP)-Au-198-EGCg) show efficacy in treating prostate cancer. Proc. Natl. Acad. Sci. USA 109, 12426-12431 (2012).
11. Huang, C. W. et al. Capturing Electrochemically Evolved Nanobubbles by Electroless Deposition. A Facile Route to the Synthesis of Hollow Nanoparticles. Nano Lett. 9, 4297-4301 (2009).
12. Huang, C., Li, Y.-J., Muangphat, C., Hao, Y. Electroless deposition of Au around electrochemically evolved hydrogen bubbles. Electrochimica Acta 56, 8319-8324 (2011).
13. Hsu, C. J., Huang, C. W., Hao, Y. W., Liu, F. Q. Synthesis of highly active and stable Au-PtCu core-shell nanoparticles for oxygen reduction reaction. Phys. Chem. Chem. Phys. 14, 14696-14701 (2012).
14. Hsu, C. J., Huang, C. W., Hao, Y. W., Liu, F. Q. Au/Pd core-shell nanoparticles for enhanced electrocatalytic activity and durability. Electrochem. Commun. 23, 133-136 (2012).
15. Hsu, C., Huang, C., Hao, Y., Liu, F. Au/Pd Core-Shell Nanoparticles with Varied Hollow Au Cores for Enhanced Formic Acid Oxidation. Nanoscale Research Letters 8, doi: 10.1186/1556-1276X-1188-1113 (2013).
16. Matsuno, F. et al. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. Clinical cancer research : an official journal of the American Association for Cancer Research 5, 371-382 (1999).
17. VanWeelden, K., Flanagan, L., Binderup, L., Tenniswood, M., Welsh, J. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. Endocrinology 139, 2102-2110 (1998).
18. Khlebtsov, N., Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chemical Society Reviews 40, 1647-1671 (2011).
19. Kelloff, G. J. et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clinical Cancer Research 11, 2785-2808 (2005).
20. Chen, K., Chen, X. Y. Positron Emission Tomography Imaging of Cancer Biology: Current Status and Future Prospects. Semin. Oncol. 38, 70-86 (2011).
21. Farwell, M. D., Pryma, D. A., Mankoff, D. A. PET/CT imaging in cancer: Current applications and future directions. Cancer 120, 3433-3445 (2014).
22. Cai, Z. L. et al. Investigation of the effects of cell model and subcellular location of gold nanoparticles on nuclear dose enhancement factors using Monte Carlo simulation. Medical Physics 40, doi: 10.1118/1111.4823787 (2013).
23. Ghorbani, M., Pakravan, D., Bakhshabadi, M., Meigooni, A. S. Dose enhancement in brachytherapy in the presence of gold nanoparticles: a Monte Carlo study on the size of gold nanoparticles and method of modelling. Nukleonika 57, 401-406 (2012).
24. Jones, B. L., Krishnan, S., Cho, S. H. Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations. Medical Physics 37, 3809-3816 (2010).
25. Roeske, J. C., Nunez, L., Hoggarth, M., Labay, E., Weichselbaum, R. R. Characterization of the theorectical radiation dose enhancement from nanoparticles. Technol. Cancer Res. Treat. 6, 395-401 (2007).
26. Pottier, A., Borghi, E., Levy, L. New Use of Metals as Nanosized Radioenhancers. Anticancer Research 34, 443-453 (2014).
27. Berdis, A. J. Current and emerging strategies to increase the efficacy of ionizing radiation in the treatment of cancer. Expert Opinion on Drug Discovery 9, 167-181 (2014).
28. Coulter, J. A., Hyland, W. B., Nicol, J., Currell, F. J. Radiosensitising Nanoparticles as Novel Cancer Therapeutics-Pipe Dream or Realistic Prospect? Clinical Oncology 25, 593-603 (2013).
29. Linkous, A. G., Yazlovitskaya, E. M. Novel Radiosensitizing Anticancer Therapeutics. Anticancer Research 32, 2487-2499 (2012).
30. Chithrani, D. B. et al. Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy. Radiation Research 173, 719-728 (2010).
31. Hainfeld, J. F., Dilmanian, F. A., Slatkin, D. N., Smilowitz, H. M. Radiotherapy enhancement with gold nanoparticles. Journal of Pharmacy and Pharmacology 60, 977-985 (2008).
32. Jeremic, B., Aguerri, A. R., Filipovic, N. Radiosensitization by gold nanoparticles. Clinical & Translational Oncology 15, 593-601 (2013).
33. McMahon, S. J. et al. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiotherapy and Oncology 100, 412-416 (2011).
34. Hainfeld, J. F. et al. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Physics in Medicine and Biology 55, 3045-3059 (2010).
35. Zhang, X. J. et al. Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. Clin. Invest. Med. 31, E160-E167 (2008).
36. Hainfeld, J. F., Slatkin, D. N., Smilowitz, H. M. The use of gold nanoparticles to enhance radiotherapy in mice. Physics in Medicine and Biology 49, N309-N315 (2004).
37. Ngwa, W. et al. In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine: Nanotechnology, Biology and Medicine 9, 25-27 (2013).
38. Cho, S. H., Jones, B. L., Krishnan, S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/X-ray sources. Physics in Medicine and Biology 54, 4889-4905 (2009).
39. Ngwa, W., Makrigiorgos, G. M., Berbeco, R. I. Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement. Physics in Medicine and Biology 55, 6533-6548 (2010).
40. Cheng, N. N. et al. Chemical Enhancement by Nanomaterials under X-ray Irradiation. Journal of the American Chemical Society 134, 1950-1953 (2012).
41. Butterworth, K. T., McMahon, S. J., Currell, F. J., Prise, K. M. Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale 4, 4830-4838 (2012).
42. Herold, D. M., Das, I. J., Stobbe, C. C., Iyer, R. V., Chapman, J. D. Gold microspheres: a selective technique for producing biologically effective dose enhancement. International Journal of Radiation Biology 76, 1357-1364 (2000).
43. Huang, C. et al. Capturing Electrochemically Evolved Nanobubbles by Electroless Deposition. A Facile Route to the Synthesis of Hollow Nanoparticles. Nano Lett. 9, 4297-4301 (2009).